WILMETTE, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with ...
The calendar and seasonally adjusted surplus stood at 20.7 billion euros in December 2024. In January 2024, the surplus was 25.3 billion euros. On a calendar and seasonally adjusted basis, Germany ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback